Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTAFR | P25105 | 1/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.35 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.35 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.35 |
| ▸ | NPC1 | O15118 | 2/20 | 0.35 |
| ▸ | LMNA | P02545 | 2/20 | 0.35 |
| ▸ | RAB9A | P51151 | 2/20 | 0.35 |
| ▸ | MAPT | P10636 | 2/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.34 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.34 |
| ▸ | TP53 | P04637 | 1/20 | 0.33 |
| ▸ | CA12 | O43570 | 1/20 | 0.33 |
| ▸ | CA1 | P00915 | 1/20 | 0.33 |
| ▸ | CA2 | P00918 | 1/20 | 0.33 |
| ▸ | CA9 | Q16790 | 1/20 | 0.33 |
| ▸ | MGLL | Q99685 | 1/20 | 0.33 |
| ▸ | PPARG | P37231 | 1/20 | 0.33 |
| ▸ | HEXA | P06865 | 1/20 | 0.33 |
| ▸ | HEXB | P07686 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL32680946 | 0.84 | PTAFR (0.36) | PTAFRSMN1; SMN2MAPK1L3MBTL1NPC1 | |
| SCHEMBL32680982 | 0.82 | EGFR (0.37) | SMN1; SMN2LMNAMAPTALDH1A1KDM4E | |
| SCHEMBL32680956 | 0.82 | GCGR (0.39) | LMNAMAPTTP53MEN1KMT2A | |
| SCHEMBL32681004 | 0.82 | SMN1; SMN2 (0.32) | SMN1; SMN2NPC1RAB9AMAPTALDH1A1 | |
| SCHEMBL32680869 | 0.82 | PTGDR2 (0.46) | SMN1; SMN2MAPK1NPC1LMNARAB9A | |
| SCHEMBL32680902 | 0.81 | PTAFR (0.37) | PTAFRSMN1; SMN2MAPK1L3MBTL1NPC1 | |
| SCHEMBL9817061 | 0.79 | CA12 (0.48) | PTAFRSMN1; SMN2MAPK1L3MBTL1NPC1 | |
| SCHEMBL32680989 | 0.79 | CYP2A6 (0.44) | ALDH1A1 | |
| SCHEMBL32680945 | 0.77 | MAPT (0.37) | SMN1; SMN2MAPK1L3MBTL1NPC1LMNA | |
| SCHEMBL32680872 | 0.76 | PARP1 (0.35) | PTAFRSMN1; SMN2NPC1LMNARAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260062607-A1 | TWO-DIMENSIONAL LATTICE CONFINED SINGLE-MOLECULE-LIKE AGGREGATES | PURDUE RESEARCH FOUNDATION (US) | 2026-03-05 | — | — | US | claimed |
| US-20260062607-A1 | TWO-DIMENSIONAL LATTICE CONFINED SINGLE-MOLECULE-LIKE AGGREGATES | PURDUE RESEARCH FOUNDATION (US) | 2026-03-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260062607-A1 | TWO-DIMENSIONAL LATTICE CONFINED SINGLE-MOLECULE-LIKE AGGREGATES | BLM, MEF2D, SNCA | PTAFR 3855/4885SMN1; SMN2 105/4885MAPK1 4082/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.